ARTICLE | Clinical News
Kynacyte: Began a Phase I trial
December 20, 1993 8:00 AM UTC
Sphinx Pharmaceuticals Corp. (SPHX) Product: Kynacyte (safingol), protein kinase C inhibitor, used alone and in combination with doxorubicin Indication: Cancer Status: Began a Phase I trial ...